Professor Senior Medical Director Dept. Of Radiation Oncology Vanderbilt University
Radiation Oncology
Dr. Anthony J. Cmelak, MD
|
|
Give Review
Doctor Anthony J. Cmelak, MD works in the field of Radiation Oncology. He graduated from Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Americas Top 1% Doctors", "Americas Top Doctors for Cancer", "Best Doctor in Middle Tennessee", "Most Compassionate Doctor Award Patients Choice Award", "Top Oncologist, The Leading Physicians of the World", "Americas Top Doctors in Cancer", "Patients Choice Award", "T.J. Martell Award for Research", "Best Doctors of America, Peer Recognition Award", "Best Teacher Award", "Travel Grant Award, Lisbon Portugal", "Buckby Medical Scholarship", "Medical Scholarship" and "Deans Honor List". Dr. Anthony J. Cmelak is also published. He has 63 publications published. The lastest publication: "Long-term depletion of naive T cells in patients treated for Hodgkin's disease.' Anthony Cmelak is registered with Medicare.
Publications
- A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced s...
- Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, con...
- Long-Term Results of Radiation Therapy Oncology Group 9903: A Randomized Phase 3 Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patie...
- Clinical and scientific impact of human papillomavirus on head and neck cancer.
- Locally advanced head and neck cancer.
- Head and Neck Cancers, Version 2.2013.
- Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.
- Segmentation editing improves efficiency while reducing inter-expert variation and maintaining accuracy for normal brain tissues in the presence of space-occupying les...
- Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of th...
- Current issues in combined modality therapy in locally advanced head and neck cancer.
- Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health.
- Intensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacy.
- Mucosal melanoma of the head and neck.
- Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinoma.
- Symptom control issues and supportive care of patients with head and neck cancers.
- Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperat...
- Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy.
- Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
- Chemoradiation therapy: the evolving role in head and neck cancer and its application to oral cavity tumors.
- Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
- A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain me...
- Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck.
- Head and neck cancers.
- Evolution of clinical trials in head and neck cancer.
- Thyroid storm after intensity-modulated radiation therapy: a case report and discussion.
- Infusion reactions associated with monoclonal antibodies in patients with solid tumors. Introduction.
- Management of infusion reactions in clinical trials and beyond: the US and EU perspectives.
- Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course.
- Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
- Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation.
- Endoscopic, image-guided, transnasal instillation of (32)P for recurrent infrachiasmatic cystic craniopharyngioma.
- Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell ca...
- Synovial sarcoma of the head and neck: a review of its diagnosis and management and a report of a rare case of orbital involvement.
- Head and neck cancers.
- Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study.
- Prevalence of secondary lymphedema in patients with head and neck cancer.
- Radiosurgery for skull base malignancies and nasopharyngeal carcinoma.
- Long-term survival with whole abdominopelvic irradiation in platinum-refractory persistent or recurrent ovarian cancer.
- Long-term depletion of naive T cells in patients treated for Hodgkin's disease.
- National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists.
- Drug-radiation interactions in tumor blood vessels.
- Combined-modality therapy for locoregionally advanced head and neck cancer.
- Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
- Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature.
- Topoisomerase I inhibitors in the treatment of head and neck cancer.
- Radiation-mediated control of drug delivery.
- Low-dose stereotactic radiosurgery is inadequate for medically intractable mesial temporal lobe epilepsy: a case report.
- The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas.
- A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-n...
- Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
- Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
- Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
- Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
- The efficacy of linear accelerator radiosurgery in the management of patients with Cushing''s disease.
- Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in ...
- Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.
- Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and nec...
- Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
- Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
- A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.
- A study on adaptive IMRT treatment planning using kV cone-beam CT.
- Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03).
Schools
Northwestern Center Feinberg School of Medicine
St Mary39s Med Center
Stanford University
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- American Republic
- Amerigroup (Wellpoint)
- Assurant Health
- Blue Card PPO
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care of Tennessee PPO
- GEHA
- Choice Care PPO
- Medicare MCR
- PHCS Network PPO
- POMCO Group
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- America’s Top 1% Doctors
- America’s Top Doctors for Cancer
- “Best Doctor in Middle Tennesseeâ€Â
- Most Compassionate Doctor Award – Patient’s Choice Award
- Top Oncologist, The Leading Physicians of the World
- America’s Top Doctors in Cancer
- Patient’s Choice Award
- T.J. Martell Award for Research
- Best Doctors of America, Peer Recognition Award
- “Best Teacher Awardâ€Â
- Travel Grant Award, Lisbon Portugal
- Buckby Medical Scholarship
- Medical Scholarship
- Deans Honor List
Education
-
Stanford University -
Northwestern University Feinberg School of Medicine -
University of California at Irvine
Hospital
-
Williamson Medical Center -
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1912099334 | |
| NPPES Provider LastName | CMELAK | |
| NPPES Provider FirstName | ANTHONY | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 59.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 11.0 | |
| Percent Opioid Claims | 18.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912099334 |
| Last Name Of The Provider | CMELAK |
| First Name Of The Provider | ANTHONY |
| View All |
Similar Doctors
|
|
Dr. Steven R. Goertz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd Tenenholz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arnold W. Malcolm, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven L. Stroup, MD |
|
|
Dr. David E. Hunt, MD |
|
|
Dr. David R. Gius, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert Attia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory R. Vlacich, MD |
|
|
Dr. Jeffrey M. Friedman, MD |
|
|
Dr. Clayton A. Smith, MD |